CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.43
9.48%
After-hours: Aug 15, 2025, 07:47 PM EDT
CNS Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.14K | 3.14K | 6.36K | 6.36K | 6.36K | 6.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.17K | 3.89K | 3.27K | 3.42K | 3.67K | 4.13K | 5.56K | 7.46K | 9.66K | 11.76K | 12.87K | 13.44K | 13.45K | 13.07K | 12.72K | 12.52K | 12.18K |
Gross Profit | -1.03K | -751 | 3.09K | 2.94K | 2.69K | 2.23K | -5.56K | -7.46K | -9.66K | -11.76K | -12.87K | -13.44K | -13.45K | -13.07K | -12.72K | -12.52K | -12.18K |
Operating Income | -15.69M | -14.9M | -17.08M | -15.99M | -17.48M | -18.87M | -18.99M | -17.87M | -17.41M | -15.27M | -12.56M | -12.95M | -13.2M | -14.03M | -14.24M | -12.43M | -11.1M |
Interest Income | 96.08K | 60.26K | 40.81K | 28.46K | 34.42K | 27.69K | 20.69K | 7.81K | 5.44 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -15.61M | -14.86M | -17.06M | -15.97M | -17.46M | -18.85M | -18.98M | -17.88M | -17.42M | -15.27M | -12.56M | -12.96M | -13.21M | -14.04M | -14.25M | -12.44M | -11.1M |
Net Income | -15.61M | -14.86M | -17.06M | -15.97M | -17.46M | -18.85M | -18.98M | -17.88M | -17.42M | -15.64M | -12.93M | -13.33M | -13.57M | -14.04M | -14.25M | -12.44M | -11.1M |
Selling & General & Admin | 5.59M | 5.61M | 5.02M | 4.76M | 4.52M | 4.77M | 5.81M | 5.9M | 6.07M | 5.97M | 4.71M | 4.74M | 4.54M | 4.68M | 4.87M | 4.61M | 4.44M |
Research & Development | 10.1M | 9.29M | 12.06M | 11.23M | 12.96M | 14.1M | 13.17M | 11.97M | 11.35M | 9.3M | 7.85M | 8.22M | 8.66M | 9.35M | 9.36M | 7.83M | 6.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.69M | 14.9M | 17.08M | 15.98M | 17.48M | 18.86M | 18.99M | 17.87M | 17.41M | 15.27M | 12.56M | 12.95M | 13.2M | 14.03M | 14.24M | 12.43M | 11.1M |
Interest Expense | 15.7K | 16.12K | 16.23K | 15.81K | 14.99K | 13.8K | 13.24K | 11.94K | 9.9K | 7.03K | 6.95K | 7.36K | 8.1K | 9.29K | 10.31K | 9.36K | 7.01K |
Selling & Marketing Expenses | n/a | -818 | -1.77K | -1.77K | -1.77K | -953 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.7M | 14.9M | 17.08M | 15.99M | 17.48M | 18.87M | 18.99M | 17.87M | 17.41M | 15.27M | 12.56M | 12.95M | 13.2M | 14.03M | 14.24M | 12.43M | 11.1M |
Income Tax Expense | n/a | n/a | -3 | -3 | -3 | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 226.31K | 1.84M | 1.84M | 4.03M | 5.13M | 5.13M | 6.93M | 6.44M | 3.16M | 2.46M | 2.16M | 2.16M | 2.08M | 1.41M | 1.49M | 1.33M | 1.33M |
Shares Outstanding (Diluted) | 226.31K | 1.84M | 1.84M | 4.05M | 5.15M | 5.15M | 6.93M | 6.44M | 3.16M | 2.46M | 2.22M | 2.22M | 2.15M | 1.54M | 1.52M | 1.41M | 1.36M |
EPS (Basic) | -673.92 | -1.01K | -987.24 | -997.2 | -384.72 | -60 | 32.04 | 43.92 | 55.32 | 85.56 | 153.84 | 153.24 | 152.52 | 151.56 | 129.00 | 129.24 | 129.24 |
EPS (Diluted) | -671.76 | -1.01K | -985.08 | -995.04 | -384.72 | -60 | 32.04 | 43.92 | 55.32 | 85.56 | 153.84 | 153.24 | 152.52 | 151.56 | 129.00 | 129.24 | 129.24 |
EBITDA | -15.64M | -14.84M | -17.04M | -15.95M | -17.45M | -18.83M | -18.96M | -17.86M | -17.4M | -15.62M | -12.91M | -13.31M | -13.55M | -14.01M | -14.22M | -12.42M | -11.08M |
EBIT | -15.6M | -14.84M | -17.04M | -15.96M | -17.45M | -18.84M | -18.97M | -17.87M | -17.41M | -15.27M | -12.56M | -12.95M | -13.2M | -14.03M | -14.24M | -12.43M | -11.1M |
Depreciation & Amortization | 3.59K | 3.31K | 3.27K | 3.42K | 3.67K | 4.13K | 5.56K | 7.46K | 9.66K | 11.76K | 12.87K | 13.44K | 13.45K | 13.07K | 12.72K | 12.52K | 12.18K |